Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Trump directed a panel headed by HHS Secretary Robert F. Kennedy Jr. to assess “the prevalence of and threat” posed by SSRIs, ...

Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...

Recent studies reveal a concerning trend of vision loss among patients using Ozempic and other weight loss products, raising ...

Eli Lilly and Company’s LLY shares have risen 4.3% since it reported fourth-quarter results on Feb. 6. Lilly’s fourth-quarter ...

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

Eli Lilly's Q4 revenue rose 45% YoY to $13.53B, driven by Mounjaro and Zepbound. Adjusted EPS hit $5.32, beating the $4.94 consensus. 2025 guidance projects $58B-$61B in sales, with a 32% growth ...

Goldberg went on to point out she had already shared information about her weight loss, revealing in March 2024 that she used Mounjaro to lose weight. “That’s the problem with AI,” Goldberg ...

The weight loss injection Mounjaro is a new treatment that can now be delivered to customers' homes by a new clinic service offered by Morrisons. Here is everything you need to know about the weight ...

One jab, Wegovy, is already available to some people and a second, Mounjaro, will soon be available - although it could be more than a decade before it is fully rolled-out. NHS experts have warned ...

The medication is sold as self-injectable products under brand names like Wegovy and Mounjaro. Prior to this guidance, patients could obtain the products by only submitting online questionnaires ...